1. Home
  2. AISP vs TENX Comparison

AISP vs TENX Comparison

Compare AISP & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

N/A

Current Price

$2.23

Market Cap

66.8M

Sector

Finance

ML Signal

N/A

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$1.93

Market Cap

74.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AISP
TENX
Founded
2006
1967
Country
United States
United States
Employees
N/A
16
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.8M
74.1M
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
AISP
TENX
Price
$2.23
$1.93
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $12.56
AVG Volume (30 Days)
191.9K
★ 3.0M
Earning Date
11-16-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 132.48
N/A
EPS
★ N/A
N/A
Revenue
★ $15,321,349.00
N/A
Revenue This Year
$78.84
N/A
Revenue Next Year
$47.81
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.69
$1.31
52 Week High
$7.20
$19.40

Technical Indicators

Market Signals
Indicator
AISP
TENX
Relative Strength Index (RSI) 53.05 29.79
Support Level $1.94 $1.31
Resistance Level $2.11 $2.22
Average True Range (ATR) 0.06 0.09
MACD 0.00 0.26
Stochastic Oscillator 81.50 58.88

Price Performance

Historical Comparison
AISP
TENX

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture. Airship AI's software allows customers to view structured data both in real-time as well as to conduct searches on the structured data at a later point in time.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: